by European Public Health Alliance | Sep 13, 2016 | Statements
On 17 June, 2016, all 28 European Union (EU) Health Ministers agreed on Council Conclusions to address the imbalances in the pharmaceutical systems in the EU and its Member States. In these Conclusions, the Ministers invited the European Commission to undertake a...
by European Public Health Alliance | Jul 1, 2016 | Opinion
By Yannis Natsis, Policy Coordinator for Universal Access & Affordable Medicines @ynatsis The Netherlands’ Presidency of the European Council proved to be far from quiet in relation to pharmaceutical affairs. June 17 was the concluding Health Ministers Council...
by European Public Health Alliance | Jun 15, 2016 | Statements
2 June 2016, Brussels. The signing Civil Society organisations call on Member States to resist pressure from the pharmaceutical industry to eliminate critical elements of proposed European Union (EU) Council Conclusions that would improve the balance between...
by European Public Health Alliance | Jun 2, 2016 | Opinion
BRUSSELS—The signing Civil Society organisations call on Member States to resist pressure from the pharmaceutical industry to eliminate critical elements of proposed European Union (EU) Council Conclusions that would improve the balance between innovation and...
by European Public Health Alliance | May 30, 2016 | Statements
This briefing is a response to an article published on May 12 2016 by four influential European regulators including the leadership of the European Medical Agency (EMA), as well as the Director of the Dutch Medicines Agency, addressing the issue of the...
